TESSENDERLO GROUP (TESB.BR) Fundamental Analysis & Valuation

EBR:TESB • BE0003555639

Current stock price

20.55 EUR
+0.05 (+0.24%)
Last:

This TESB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. TESB.BR Profitability Analysis

1.1 Basic Checks

  • In the past year TESB has reported negative net income.
  • In the past year TESB had a positive cash flow from operations.
  • Of the past 5 years TESB 4 years were profitable.
  • TESB had a positive operating cash flow in each of the past 5 years.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • TESB has a worse Return On Assets (-0.96%) than 60.87% of its industry peers.
  • With a Return On Equity value of -1.52%, TESB perfoms like the industry average, outperforming 40.58% of the companies in the same industry.
  • With a Return On Invested Capital value of 2.47%, TESB perfoms like the industry average, outperforming 47.83% of the companies in the same industry.
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROIC 2.47%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • TESB has a Operating Margin of 2.61%. This is in the lower half of the industry: TESB underperforms 62.32% of its industry peers.
  • In the last couple of years the Operating Margin of TESB has declined.
  • TESB's Gross Margin of 19.33% is on the low side compared to the rest of the industry. TESB is outperformed by 72.46% of its industry peers.
  • In the last couple of years the Gross Margin of TESB has declined.
Industry RankSector Rank
OM 2.61%
PM (TTM) N/A
GM 19.33%
OM growth 3Y-38.94%
OM growth 5Y-23.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-7.25%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TESB.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TESB is destroying value.
  • There is no outstanding debt for TESB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • TESB has an Altman-Z score of 1.87. This is not the best score and indicates that TESB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • TESB has a worse Altman-Z score (1.87) than 63.77% of its industry peers.
  • The Debt to FCF ratio of TESB is 2.34, which is a good value as it means it would take TESB, 2.34 years of fcf income to pay off all of its debts.
  • TESB has a better Debt to FCF ratio (2.34) than 89.86% of its industry peers.
  • TESB has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of TESB (0.06) is better than 88.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Altman-Z 1.87
ROIC/WACC0.35
WACC7.06%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.94 indicates that TESB should not have too much problems paying its short term obligations.
  • TESB has a Current ratio of 1.94. This is in the better half of the industry: TESB outperforms 60.87% of its industry peers.
  • TESB has a Quick Ratio of 1.18. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
  • TESB has a Quick ratio of 1.18. This is comparable to the rest of the industry: TESB outperforms 53.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TESB.BR Growth Analysis

3.1 Past

  • TESB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.18%.
  • TESB shows a small growth in Revenue. In the last year, the Revenue has grown by 2.05%.
  • The Revenue has been growing by 9.72% on average over the past years. This is quite good.
EPS 1Y (TTM)-131.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.23%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y2.21%
Revenue growth 5Y9.72%
Sales Q2Q%7.08%

3.2 Future

  • TESB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.12% yearly.
  • The Revenue is expected to grow by 3.35% on average over the next years.
EPS Next Y45.72%
EPS Next 2Y30.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.96%
Revenue Next 2Y3.94%
Revenue Next 3Y3.35%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

6

4. TESB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TESB. In the last year negative earnings were reported.
  • TESB is valuated reasonably with a Price/Forward Earnings ratio of 10.86.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TESB indicates a rather cheap valuation: TESB is cheaper than 88.41% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of TESB to the average of the S&P500 Index (23.13), we can say TESB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.86
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TESB indicates a rather cheap valuation: TESB is cheaper than 95.65% of the companies listed in the same industry.
  • TESB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TESB is cheaper than 88.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.03
EV/EBITDA 3.94
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • TESB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • TESB's earnings are expected to grow with 30.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.12%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. TESB.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.54%, TESB has a reasonable but not impressive dividend return.
  • In the last 3 months the price of TESB has falen by -21.76%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 2.35, TESB pays a bit more dividend than its industry peers.
  • TESB's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.54%

5.2 History

  • On average, the dividend of TESB grows each year by 6.16%, which is quite nice.
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • The earnings of TESB are negative and hence is the payout ratio. TESB will probably not be able to sustain this dividend level.
  • The dividend of TESB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-166.05%
EPS Next 2Y30.12%
EPS Next 3YN/A
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

More info and screens

Find the best dividend stocksShow peers with best dividend

TESB.BR Fundamentals: All Metrics, Ratios and Statistics

TESSENDERLO GROUP

EBR:TESB (4/7/2026, 10:03:13 AM)

20.55

+0.05 (+0.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-01
Earnings (Next)N/A
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners68.68%
Ins Owner ChangeN/A
Market Cap1.21B
Revenue(TTM)2.75B
Net Income(TTM)-27.10M
Analysts76.36
Price Target27.54 (34.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.54%
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP-166.05%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)7.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.86
P/S 0.44
P/FCF 11.03
P/OCF 4.21
P/B 0.68
P/tB 0.78
EV/EBITDA 3.94
EPS(TTM)-0.45
EYN/A
EPS(NY)1.89
Fwd EY9.21%
FCF(TTM)1.86
FCFY9.06%
OCF(TTM)4.89
OCFY23.78%
SpS46.5
BVpS30.17
TBVpS26.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROCE 3.29%
ROIC 2.47%
ROICexc 2.77%
ROICexgc 3.14%
OM 2.61%
PM (TTM) N/A
GM 19.33%
FCFM 4.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-38.94%
OM growth 5Y-23.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-7.25%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Debt/EBITDA 0.38
Cap/Depr 80.05%
Cap/Sales 6.5%
Interest Coverage 7.18
Cash Conversion 97.86%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.18
Altman-Z 1.87
F-Score6
WACC7.06%
ROIC/WACC0.35
Cap/Depr(3y)77.15%
Cap/Depr(5y)77.84%
Cap/Sales(3y)6.13%
Cap/Sales(5y)5.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.23%
EPS Next Y45.72%
EPS Next 2Y30.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y2.21%
Revenue growth 5Y9.72%
Sales Q2Q%7.08%
Revenue Next Year3.96%
Revenue Next 2Y3.94%
Revenue Next 3Y3.35%
Revenue Next 5YN/A
EBIT growth 1Y11.66%
EBIT growth 3Y-37.59%
EBIT growth 5Y-15.72%
EBIT Next Year250.18%
EBIT Next 3Y53.49%
EBIT Next 5YN/A
FCF growth 1Y-13.45%
FCF growth 3Y-4.9%
FCF growth 5Y-16.41%
OCF growth 1Y1.8%
OCF growth 3Y4.15%
OCF growth 5Y-4.38%

TESSENDERLO GROUP / TESB.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TESSENDERLO GROUP?

ChartMill assigns a fundamental rating of 4 / 10 to TESB.BR.


Can you provide the valuation status for TESSENDERLO GROUP?

ChartMill assigns a valuation rating of 6 / 10 to TESSENDERLO GROUP (TESB.BR). This can be considered as Fairly Valued.


What is the profitability of TESB stock?

TESSENDERLO GROUP (TESB.BR) has a profitability rating of 2 / 10.


What is the financial health of TESSENDERLO GROUP (TESB.BR) stock?

The financial health rating of TESSENDERLO GROUP (TESB.BR) is 5 / 10.


What is the expected EPS growth for TESSENDERLO GROUP (TESB.BR) stock?

The Earnings per Share (EPS) of TESSENDERLO GROUP (TESB.BR) is expected to grow by 45.72% in the next year.